These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8040116)
1. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. Mtairag EM; Abdelghaffar H; Labro MT J Antimicrob Chemother; 1994 Mar; 33(3):523-36. PubMed ID: 8040116 [TBL] [Abstract][Full Text] [Related]
2. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Abdelghaffar H; Mtairag EM; Labro MT Antimicrob Agents Chemother; 1994 Jul; 38(7):1548-54. PubMed ID: 7979287 [TBL] [Abstract][Full Text] [Related]
3. Interactions of dirithromycin with human polymorphonuclear leukocytes. Hand WL; Hand DL Antimicrob Agents Chemother; 1993 Dec; 37(12):2557-62. PubMed ID: 8109917 [TBL] [Abstract][Full Text] [Related]
4. In vitro interaction between dirithromycin or its metabolite, erythromycylamine, and oxidative polymorphonuclear metabolism. Moutard I; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC J Antibiot (Tokyo); 1997 Jan; 50(1):53-7. PubMed ID: 9066766 [TBL] [Abstract][Full Text] [Related]
5. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin. Shinkai I; Ohta Y Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin. Jooné GK; Van Rensburg CE; Anderson R J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dirithromycin. Sides GD; Cerimele BJ; Black HR; Busch U; DeSante KA J Antimicrob Chemother; 1993 Mar; 31 Suppl C():65-75. PubMed ID: 8478313 [TBL] [Abstract][Full Text] [Related]
8. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Mtairag EM; Abdelghaffar H; Douhet C; Labro MT Antimicrob Agents Chemother; 1995 Aug; 39(8):1676-82. PubMed ID: 7486899 [TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva. Geerdes-Fenge HF; Goetschi B; Rau M; Borner K; Koeppe P; Wettich K; Lode H Eur J Clin Pharmacol; 1997; 53(2):127-33. PubMed ID: 9403284 [TBL] [Abstract][Full Text] [Related]
10. Tonsillar tissue penetration of dirithromycin after multiple doses. Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904 [TBL] [Abstract][Full Text] [Related]
11. Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro. Abdelghaffar H; Vazifeh D; Labro MT J Antimicrob Chemother; 1996 Jul; 38(1):81-93. PubMed ID: 8858460 [TBL] [Abstract][Full Text] [Related]
12. Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst. Levert H; Gressier B; Brunet C; Dine T; Luyckx M; Ballester L; Templier F; Cazin M; Cazin JC J Antibiot (Tokyo); 1999 Feb; 52(2):127-33. PubMed ID: 10344566 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial characterization and interrelationships of dirithromycin and epidirithromycin. Kirst HA; Creemer LC; Paschal JW; Preston DA; Alborn WE; Counter FT; Amos JG; Clemens RL; Sullivan KA; Greene JM Antimicrob Agents Chemother; 1995 Jul; 39(7):1436-41. PubMed ID: 7492081 [TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of dirithromycin: comparison with erythromycin. Bergogne-Bérézin E J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314 [TBL] [Abstract][Full Text] [Related]
15. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. Labro MT; el Benna J; Abdelghaffar H J Antimicrob Chemother; 1993 Mar; 31 Suppl C():51-64. PubMed ID: 8478312 [TBL] [Abstract][Full Text] [Related]
16. Cellular uptake of two fluoroketolides, HMR 3562 and HMR 3787, by human polymorphonuclear neutrophils in vitro. Abdelghaffar H; Vazifeh D; Labro MT Antimicrob Agents Chemother; 2001 Oct; 45(10):2798-806. PubMed ID: 11557472 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin. Counter FT; Ensminger PW; Preston DA; Wu CY; Greene JM; Felty-Duckworth AM; Paschal JW; Kirst HA Antimicrob Agents Chemother; 1991 Jun; 35(6):1116-26. PubMed ID: 1929252 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of dirithromycin against Chlamydia trachomatis. Segreti J; Kapell KS Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051 [TBL] [Abstract][Full Text] [Related]
19. Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G Chemotherapy; 1992; 38(6):433-40. PubMed ID: 1288969 [TBL] [Abstract][Full Text] [Related]
20. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]